Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$29,763,248
-$5,455,664 QoQ
Shares Held
117,192
-18.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
#591
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEEDER ASSET MANAGEMENT INC holds $140,500,918 across 9 Drug Manufacturers - General names. JNJ ranks #2 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,922 | $34,689,912 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
117,192 | $29,763,248 | |
| 3 | ABBV |
AbbVie Inc.
|
98,512 | $24,789,557 | |
| 4 | AMGN |
Amgen Inc
|
65,451 | $23,701,113 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
135,547 | $17,125,003 | |
| 6 | MRK |
Merck & Co., Inc.
|
71,755 | $9,220,516 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
20,426 | $1,176,942 | |
| 8 | PFE |
Pfizer Inc
|
1,115 | $26,849 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,763,248 | 117,192 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $35,218,912 | 144,080 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $24,518,604 | 118,476 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,541,951 | 8,316 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $7,017,025 | 45,938 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $12,928,385 | 77,957 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,390,615 | 23,445 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $33,086,490 | 204,162 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $36,083,688 | 246,878 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $21,016,490 | 132,856 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $4,886,055 | 31,173 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $19,315,803 | 124,018 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,274,250 | 56,031 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $24,683,440 | 159,248 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,824,848 | 95,244 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,558,160 | 156,453 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $26,795,664 | 150,953 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $26,480,284 | 149,412 | Shares | Defined | 2022-05-10 | |
| 2021-09-30 | $23,729,194 | 146,930 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $25,062,719 | 152,135 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $24,645,265 | 149,956 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $2,889,339 | 18,359 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $22,451,398 | 150,802 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $19,608,459 | 139,433 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $14,747,531 | 112,465 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||